CLINICAL_TRIALS
trial_result
· 2025-05-31
Clinical Trial Update: Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 clinical trial of CC-96191 in participants with relapsed or refractory acute myeloid leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Leukemia, Myeloid | Phase 1 | Status: TERMINATED